account_balance
Investment manager · 13F filer · SEC CIK 1388551
Caxton Corp
Reported value$1.85Mas of Jun 30, 2026
Positions10 4 new, 1 sold out
Top 10 weight100.0%SPCX alone is 24%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 10 stocks.
SPCXSpace Exploration Technologies Corp
24.0%New
BRK-BBerkshire Hathaway Inc
20.3%Added +4%
GOOGLAlphabet Inc.
13.3%New
VOOVanguard Index FDS
12.6%New
BXBlackstone Inc.
10.2%New
KYTXKyverna Therapeutics, Inc.
5.9%Trimmed −34%
LXEOLexeo Therapeutics, Inc.
4.3%Added +22%
XFORX4 Pharmaceuticals, Inc
3.9%
IKTInhibikase Therapeutics, Inc.
3.1%
ALXO2.3%SPCXSpace Exploration Technologies Corp
24.0%New
BRK-BBerkshire Hathaway Inc
20.3%Added +4%
GOOGLAlphabet Inc.
13.3%New
VOOVanguard Index FDS
12.6%New
BXBlackstone Inc.
10.2%
KYTXLXEO4.3%XFOR3.9%IKT3.1%ALXO2.3%Box size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 10 as a list
SPCX Space Exploration Technologies Corp 24.0% NewBRK-B Berkshire Hathaway Inc 20.3% Added +4%GOOGL Alphabet Inc. 13.3% New
VOO Vanguard Index FDS 12.6% New
BX Blackstone Inc. 10.2% NewKYTX Kyverna Therapeutics, Inc. 5.9% Trimmed −34%LXEO Lexeo Therapeutics, Inc. 4.3% Added +22%XFOR X4 Pharmaceuticals, Inc 3.9% HeldIKT Inhibikase Therapeutics, Inc. 3.1% HeldALXO Alx Oncology Holdings Inc 2.3% HeldWhat changed
Biggest moves since Mar 31, 2026
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.